• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国儿童急性淋巴细胞白血病患者血浆甲氨蝶呤水平和 MTHFR 基因型的影响。

Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia.

机构信息

Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

J Chemother. 2020 Sep;32(5):251-259. doi: 10.1080/1120009X.2020.1764280. Epub 2020 May 20.

DOI:10.1080/1120009X.2020.1764280
PMID:32431230
Abstract

Whether plasma MTX concentrations and MTHFR C677T and A1298C polymorphisms could be used as a predictor of occurrence of MTX-related toxicities in Korean paediatric patients with acute lymphoblastic leukaemia (ALL) were assessed. HD-MTX related toxicities, MTHFR polymorphisms and MTX plasma concentrations following 337 HD-MTX cycles to 117 children with ALL on maintenance therapy were analyzed. A significantly higher frequency of hyperbilirubinemia ( = 0.0443) and renal toxicity ( = 0.0107) were associated with high MTX concentrations by Fisher's exact test. Moreover, high MTX concentrations at 24 h, 48, and 72 h were significantly associated with increased frequency of vomiting ( < 0.05) and hyperbilirubinemia ( < 0.05) by Mann-Whitney U test. There was a significantly higher frequency of mucositis in patients with the MTHFR 677 TT genotype ( = 0.0273) and a significantly higher frequency of MTX dose reduction in patients with the 677 TT genotype ( = 0.0217), compared to the CC/CT genotype. Independently, plasma MTX concentrations and MTHFR C677T genotype could be useful markers for tailoring MTX dosing and monitoring adverse effects in childhood ALL HD-MTX therapy in Korean patients.

摘要

评估了血浆 MTX 浓度和 MTHFR C677T 和 A1298C 多态性是否可用于预测韩国儿童急性淋巴细胞白血病(ALL)患者接受大剂量甲氨蝶呤(HD-MTX)治疗时发生 MTX 相关毒性的情况。对 117 例接受维持治疗的 ALL 患儿进行了 337 次 HD-MTX 周期的 HD-MTX 相关毒性、MTHFR 多态性和 MTX 血浆浓度分析。Fisher 确切检验显示,高 MTX 浓度与高胆红素血症(=0.0443)和肾毒性(=0.0107)的发生率显著相关。此外,24 小时、48 小时和 72 小时 MTX 浓度较高与呕吐(<0.05)和高胆红素血症(<0.05)的发生率增加显著相关,通过 Mann-Whitney U 检验。MTHFR 677 TT 基因型患者的黏膜炎发生率明显更高(=0.0273),677 TT 基因型患者的 MTX 剂量减少发生率明显更高(=0.0217),与 CC/CT 基因型相比。独立地,血浆 MTX 浓度和 MTHFR C677T 基因型可能是韩国儿童 ALL HD-MTX 治疗中调整 MTX 剂量和监测不良反应的有用标志物。

相似文献

1
Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia.韩国儿童急性淋巴细胞白血病患者血浆甲氨蝶呤水平和 MTHFR 基因型的影响。
J Chemother. 2020 Sep;32(5):251-259. doi: 10.1080/1120009X.2020.1764280. Epub 2020 May 20.
2
Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.利用亚甲基四氢叶酸还原酶(MTHFR)C677T基因多态性和血浆药代动力学预测急性淋巴细胞白血病患者的甲氨蝶呤毒性
Adv Clin Exp Med. 2018 Aug;27(8):1061-1068. doi: 10.17219/acem/69802.
3
Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.亚甲基四氢叶酸还原酶C677T和A1298C基因多态性与急性淋巴细胞白血病和非霍奇金淋巴瘤患儿治疗相关毒性
Leuk Lymphoma. 2009 Jun;50(6):912-7. doi: 10.1080/10428190902893819.
4
Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.亚甲基四氢叶酸还原酶(MTHFR)基因多态性对急性淋巴细胞白血病中氨甲蝶呤诱导毒性的影响:一项荟萃分析。
Tumour Biol. 2012 Oct;33(5):1445-54. doi: 10.1007/s13277-012-0395-2. Epub 2012 Apr 20.
5
Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic Leukemia.亚甲基四氢叶酸还原酶基因的遗传变异是孟加拉国急性淋巴细胞白血病患者甲氨蝶呤毒性的重要预测因子。
Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):e58-e65. doi: 10.1016/j.clml.2019.11.020. Epub 2019 Dec 5.
6
Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.叶酸代谢途径中遗传多态性与儿童急性淋巴细胞白血病和恶性淋巴瘤中甲氨蝶呤药代动力学和毒性的关系。
Eur J Clin Pharmacol. 2011 Oct;67(10):993-1006. doi: 10.1007/s00228-011-1046-z. Epub 2011 Apr 21.
7
Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.研究高剂量甲氨蝶呤治疗儿童急性淋巴细胞白血病的药代动力学和药物遗传学毒性贡献。
Med Oncol. 2012 Sep;29(3):2053-62. doi: 10.1007/s12032-011-9997-6. Epub 2011 Jun 5.
8
Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico.在墨西哥,急性白血病患者中氨甲蝶呤诱导的粘膜炎与亚甲基四氢叶酸还原酶(MTHFR)677T等位基因无关。
Hematology. 2007 Oct;12(5):387-91. doi: 10.1080/10245330701448479.
9
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.亚甲基四氢叶酸还原酶基因的C677T和A1298C多态性:对成人急性淋巴细胞白血病中与甲氨蝶呤相关毒性的影响
Blood Coagul Fibrinolysis. 2013 Mar;24(2):181-8. doi: 10.1097/MBC.0b013e32835b249d.
10
Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.甲氨蝶呤代谢途径基因多态性对血液系统恶性肿瘤成人患者甲氨蝶呤毒性和血药浓度的影响。
Pharmacogenomics. 2014 Aug;15(11):1479-94. doi: 10.2217/pgs.14.97.

引用本文的文献

1
Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients.系统评价:高剂量甲氨蝶呤在儿科急性淋巴细胞白血病患者药代动力学中的遗传多态性。
Cancer Chemother Pharmacol. 2024 Aug;94(2):141-155. doi: 10.1007/s00280-024-04694-0. Epub 2024 Jul 13.
2
Involvement of the Variant but Not the or Variant in High-Dose Methotrexate-Induced Toxicity in Pediatric Acute Lymphoblastic Leukemia Patients in China.中国儿童急性淋巴细胞白血病患者中,变异体而非其他变异体参与高剂量甲氨蝶呤诱导的毒性反应。
Int J Gen Med. 2024 Mar 27;17:1221-1231. doi: 10.2147/IJGM.S453394. eCollection 2024.
3
Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity.
亚甲基四氢叶酸还原酶基因多态性与甲氨蝶呤药物代谢及毒性之间的关系。
Transl Pediatr. 2023 Jan 31;12(1):31-45. doi: 10.21037/tp-22-671. Epub 2023 Jan 16.
4
Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia.基因多态性对中国急性淋巴细胞白血病患者甲氨蝶呤血药浓度及毒性的影响
Blood Sci. 2022 Nov 11;5(1):32-38. doi: 10.1097/BS9.0000000000000142. eCollection 2023 Jan.
5
The Role of Single Nucleotide Polymorphisms in Transporter Proteins and the Folate Metabolism Pathway in Delayed Methotrexate Excretion: A Case Report and Literature Review.单核苷酸多态性在转运蛋白及叶酸代谢途径中对甲氨蝶呤排泄延迟的作用:一例报告及文献综述
Pharmgenomics Pers Med. 2022 Nov 2;15:919-926. doi: 10.2147/PGPM.S376797. eCollection 2022.
6
The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia.亚甲基四氢叶酸还原酶(MTHFR)基因多态性对小儿急性淋巴细胞白血病甲氨蝶呤治疗的影响。
Open Life Sci. 2021 Nov 6;16(1):1203-1212. doi: 10.1515/biol-2021-0121. eCollection 2021.
7
The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis.基因多态性在血液系统恶性肿瘤高剂量甲氨蝶呤毒性及反应中的作用:一项系统评价和荟萃分析
Front Pharmacol. 2021 Oct 21;12:757464. doi: 10.3389/fphar.2021.757464. eCollection 2021.